Table of Contents Table of Contents
Previous Page  1396 / 1851 Next Page
Information
Show Menu
Previous Page 1396 / 1851 Next Page
Page Background

Hodgkin’s Disease – Stanford Clinical Trial (late ‘60)

Stage I-IIA IF vs (S)TLI

RT dose: 40 Gy